Document:

Dragon Waiver

 Exhibit 10.67 
  
 October 7th, 2004 
  
 Steven J. Davis, General Counsel 
 Molecular Imaging Corporation 

9530 Towne Centre Drive, Suite #120 
 San Diego, California 92121

  

	Re:	Securities Purchase Agreement 

  
 Dear Steve: 
  
 Reference is made to the Securities Purchase Agreement dated as of July 12, 2002 (the “Agreement”) by and among Molecular Imaging Corporation (the “Company”), Ivan Bradbury and
Integrated Healthcare Management, S.A., as such Agreement was assigned to Dragon Nominees Limited (“Purchaser”). 
  
 Effective as of the date that Mr. Kenneth Frederick becomes the Chief Executive Officer of the Company, Dragon agrees to waive its rights under Sections 4.06 (a), (b),
(c) and (d) of the Agreement with respect to the nomination of a Purchaser Designee (as defined in the Agreement) to the Company’s Board of Directors, until the first to occur of (i) the date which is six (6) months after the effective date
that Mr. Frederick becomes CEO or (ii) the date which Mr. Frederick is no longer a member of the Company’s Board of Directors. 
  
 Sincerely, 
  

			
	Dragon Nominees Limited
		
	By:	 	/S/    IVAN
BRADBURY        

  
 Acknowledged and Agreed: 

 

			
	Molecular Imaging Corporation
		
	By:	 	/S/    STEVEN J.
DAVISFirst Amendment to Dragon Subscription

 Exhibit 10.68 
  
 MOLECULAR IMAGING CORPORATION 
 Shares of Series C Convertible Preferred Stock 
  
 FIRST AMENDMENT TO SUBSCRIPTION AGREEMENT 
  
 This First Amendment to Subscription Agreement (the “Amendment”) is entered into and effective as of July 16, 2004 by and between Molecular Imaging Corporation (the
“Company”) and Dragon Nominees Limited (the “Purchaser”), with reference to the following facts: 
  
 A. The Company and Purchaser entered into a Subscription Agreement dated as of June 8, 2004 (the “Agreement”) pursuant to which
the Company filed a Certificate of Designations of Series C Preferred Stock (the “Certificate of Designations”) with the Secretary of State of the State of Delaware creating a Series C Convertible Preferred Stock (the
“Series C Stock”), and the Company sold 1,100,000 shares of Series C Stock to Purchaser. 
  
 B. The parties desire to amend the Agreement and the Certificate of Designations with this Amendment with respect to certain registration rights.

  
 Now, therefore, in consideration of the mutual covenants,
conditions, and agreements in this Agreement, the parties agree as follows: 
  
 1. Registration Rights. Paragraph 10 of the Agreement shall be deleted in its entirety and replaced with the following: 
  

“10. Registration Rights. On or before February 15, 2005, the Company shall prepare and file with the Securities and
Exchange Commission (the “SEC”) a Registration Statement covering the resale of the Conversion Shares and the Warrant Shares (collectively, the “Registrable Securities”) for an offering to be made on a
continuous basis pursuant to Rule 415 (the “Registration Statement”). The Registration Statement required hereunder shall be on Form SB-2. The Company shall register (i) 22,000,000 Conversion Shares, (ii) 1,000,000 Warrant
Shares, and (iii) all other Registrable Securities (as defined in the Registration Rights Agreement (as defined below)) held by Purchaser as of the date of this Amendment. The Company shall use diligent efforts to cause such Registration Statement
to become effective within 90 days after the initial filing with the SEC, but shall not be liable for any damages should such effectiveness be delayed by the SEC review process. The Company shall use diligent efforts to keep such Registration
Statement continuously effective under the Securities Act until the date which is two years after the date that such Registration Statement is declared effective by the SEC or such earlier date when all Registrable Securities under this Agreement or
the Registration Rights Agreement covered by such Registration Statement have been sold or may be sold without volume restrictions pursuant to Rule 144(k) as determined by the counsel to the Company pursuant to a written opinion to such effect
addressed and acceptable to the Company’s transfer agent. With respect to the Registration Statement, the Company shall comply, mutatis mutandis, with Sections 4(c), 4(d), 4(f), 4(g), 4(h), 4(i), 4(j), 7, 9 and 11 (provided, however, such
rights shall inure only to a successor assignee of Purchaser as permitted under Section 15 hereof) of the Registration Rights Agreement, dated July 31, 2002, by and between the Company and Purchaser (the “Registration Rights
Agreement”).” 

 2. Certificate of Designations. Purchaser waives the definition of “Event of Default” in
paragraph (g)(iii)(b) of the Certificate of Designations and agrees that such paragraph (g)(iii)(b) shall be deemed to contain the following: 
  
 “(ii) file a registration statement (the “Registration Statement”) with the Securities and Exchange
Commission (the “SEC”) on or before February 15, 2005;” 
  
 As holder of all of the issued and outstanding Series C Stock, Purchaser approves and authorizes the Company to file with the Secretary of State of the State of Delaware any required amendment to the Certificate of Designations to reflect
the change set forth in this Paragraph 2. 
  
 3. Effect of
Amendment. All other terms of the Agreement and Certificate of Designations shall remain in full force and effect as amended in this Amendment. 
  
 4. Counterparts; Facsimile Transmission. This Amendment may be executed in two or more counterparts and may be delivered by facsimile transmission,
each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
  
 IN WITNESS WHEREOF, this Amendment has been duly executed and delivered by the duly authorized officer of each party hereto as of the date first written
above. 
  

			
	Molecular Imaging Corporation
		
	By:	 	/S/    STEVEN J.
DAVIS        
	 	 	 Steven J. Davis
 Corporate Secretary

  
 Dated: October 12, 2004

  

			
	Dragon Nominees Limited
		
	By:	 	/S/    IVAN
BRADBURY        

  
 Dated: October 7, 2004

  

 2Employment Agreement

 Exhibit 10.69 
  
 EMPLOYMENT AGREEMENT 
  
 THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of October 12, 2004 by and between Molecular Imaging
Corporation, a Delaware corporation (the “Company”) and Kenneth C. Frederick (the “Employee”). 
  
  
 BACKGROUND 
  
 A.    The Company desires to retain the services of the
Employee and the Employee desires to provide services, as Chief Executive Officer of the Company from the date of this Agreement (the “Effective Date”). 
  
 B.    The Employee is willing to be employed by the Company on the terms and subject to the conditions
set forth in this Agreement. 
  
 THE PARTIES AGREE AS FOLLOWS:

  
 1.    Positions and Duties.

  
 1.1    Title.    The Employee shall be employed by the Company as its Chief Executive Officer and the Company agrees to employ and retain the Employee in such capacity. The Employee
shall report to, and serve at the pleasure of, the Company Board of Directors (the “Board”). 
  
 1.2    Duties.    The Employee shall devote substantially all of his business time, energy, and
skill to the affairs of the Company; provided, however, that reasonable time for personal business, charitable or professional activities shall be permitted, so long as such activities do not materially interfere with the Employee’s performance
of services under this Agreement. The Employee’s services shall be primarily performed at San Diego, California, unless otherwise agreed by the Company. 
  
 1.3    Term of Employment.    The term of Employee’s employment pursuant to this Agreement
shall commence on the Effective Date, and shall expire on November 15, 2005, unless renewed or extended by the agreement of the parties hereto; provided, however, the Board (with the Employee abstaining from any such vote of the Board at such time)
may terminate the Agreement for any reason on or after May 15, 2004 by providing written notice to the Employee. 
  
 1.4    Employee Indemnification.    The Employee shall be entitled to all rights to indemnification
as a Company director and officer as provided under the laws of the State of Delaware, the Company’s Certificate of Incorporation, as amended, the Company’s Bylaws, and the Company’s insurance policies. 
  
 2.    Terms of Employment. 
  
 2.1    Definitions.    For purposes of this Agreement, the following terms shall have the following meanings: 

 (a)    “Accrued Compensation” shall mean any accrued Total
Cash Compensation, any benefits under any plan of the Company in which the Employee is a participant to the full extent of Employee’s rights under such plans, any accrued vacation pay, and any appropriate business expenses incurred by the
Employee in connection with the performance of Employee’s duties hereunder, all to the extent unpaid on the date of termination. 
  
 (b)    “Base Salary” shall have the meaning set forth in Section 3.1 hereof. 
  
 (c)    “Death Termination” shall
mean termination of the Employee’s employment because of the death of the Employee. 
  
 (d)    “Disability Termination” means termination by the Company of the Employee’s employment by reason of the Employee’s incapacitation due to disability. The
Employee shall be deemed to be incapacitated due to disability if at the end of any month the Employee is unable to perform substantially all of his or her duties under this Agreement in the normal and regular manner due to illness, injury or mental
or physical incapacity, and has been unable so to perform for either (i) three consecutive full calendar months then ending, or (ii) 90 or more of the normal working days during the 12 consecutive full calendar months then ending. Nothing in this
paragraph shall alter the Company’s obligations under applicable law, which may, in certain circumstances, result in the suspension or alteration of the foregoing time periods. 
  
 (e)    “Termination For Cause” means termination by the Company of the
Employee’s employment by reason of the Employee’s (i) dishonesty or fraud, (ii) gross negligence in the performance of his or her duties hereunder, (iii) material breach of this Agreement, (iv) intentional engagement in acts seriously
detrimental to the Company’s operations, (v) conviction of a felony involving moral turpitude, or (vi) failure to comply with any lawful orders or directions of the Board that are not incompatible with his position with the Company or
manifestly unreasonable or unethical, provided that the Board delivers to Employee a written notification specifying in sufficient detail such order or direction and the Employee has thirty (30) days within which to comply with such order or
direction (or such reasonably shorter period of time if such ordered or directed task by its nature requires completion in less than thirty (30) days)). 
  
 (f)    “Termination Other Than For Cause” means termination by the Company of the Employee’s employment
for any reason other than as specified in Sections 2.1(c), (d), (e) or (h) hereof. 
  
 (g)    “Total Cash Compensation” shall mean the Employee’s Base Salary (as defined in Section 3.1) plus any cash bonuses, commissions or similar incentive payment
accrued during any single calendar year. 
  
 (h)    “Voluntary Termination” means termination of the Employee’s employment by the voluntary action of the Employee other than by reason of a Disability Termination or a Death Termination.

  

 2 

 2.2    Termination For Cause.    Upon Termination
For Cause, the Company shall pay the Employee Accrued Compensation, if any. 
  
 2.3    Termination Other Than For Cause; Expiration.    Upon Termination Other Than For Cause on or after May 15, 2004 and before the expiration of the Employment
Agreement, the Company shall pay the Employee all Accrued Compensation, if any, and shall continue to pay the Employee Base Salary, at the rate and upon the normal payroll schedule in effect at the time of termination, from the date of termination
until the latest to occur between (i) November 15, 2005 or (ii) the date which is three (3) months after the date of termination. Upon the expiration of the term of the Employment Agreement, the Company shall continue to pay the Employee Base
Salary, at the rate and upon the normal payroll schedule in effect at the time of expiration, for a period of three (3) months from the date of expiration of the term. 
  
 2.4    Disability Termination.    The Company shall have the right to
effect a Disability Termination by giving written notice thereof to the Employee. Upon Disability Termination, the Company shall pay the Employee all Accrued Compensation, if any, and shall continue to pay the Employee Base Salary for a period of
three (3) months from the date of termination at the rate and upon the normal payroll schedule in effect at the time of termination. 
  
 2.5    Death Termination.    In the event of the Employee’s death during the term of this
Agreement, the Employee’s employment shall be deemed to have terminated as of the last day of the month during which his or her death occurs, and the Company shall promptly pay to the Employee’s estate Accrued Compensation, if any, and
shall continue to pay the Employee’s estate the Employee Base Salary for a period of three (3) months from the date of termination at the rate and upon the normal payroll schedule in effect at the time of termination. 
  
 2.6    Voluntary
Termination.    The Employee shall have the right to effect a Voluntary Termination by giving at least 30 days advance written notice to the Company. The Company shall have the right in such case to immediately terminate
the Employee’s employment. Following the effective date of a Voluntary Termination, the Company shall pay the Employee Accrued Compensation, if any. 
  
 2.7    Timing of Termination Payments.    Unless expressly provided otherwise, the foregoing
termination payments shall be made at the usual and agreed times provided for in Section 3.1 of this Agreement. 
  
 3.    Salary, Benefits, Housing Allowance, Bonus, Equity Compensation. 
  
 3.1    Base
Salary.    As payment for the services to be rendered by the Employee as provided in Section 1 and subject to the provisions of Section 2 of this Agreement, the Company shall pay the Employee a “Base Salary” at
the rate of $21,666.66 per month (equivalent to $260,000.00 per year), payable on the Company’s normal payroll schedule. 
  
 3.2    Fringe Benefits. 
  
 (a)    Fringe Benefits.    The Employee shall be eligible to participate in such of the
Company’s benefit plans as are now generally available or later made generally 
  

 3 

 available to senior officers of the Company, including, without limitation, medical, dental, life, and disability
insurance plans. 
  
 (b)    Expense
Reimbursement.    The Company agrees to reimburse the Employee for all reasonable, ordinary and necessary travel and entertainment expenses incurred by the Employee in conjunction with Employee’s services to the
Company consistent with the Company’s standard reimbursement policies. The Company shall pay travel costs incurred by the Employee in conjunction with his or her services to the Company consistent with the Company’s standard travel policy.

  
 (c)    Vacation.    The Employee shall be entitled, without loss of compensation, to four (4) weeks of vacation per year. Unused vacation may be accrued by the Employee up to a maximum
of four (4) weeks, when it will cease accruing until the Employee reduces the accrued, unused amount through use of vacation time. 
  
 3.3    Housing Allowance.    The Employee shall be reimbursed for his housing and travel expenses
relating to his commute to the Company’s corporate offices located in San Diego, California, not to exceed the amount of $4000.00 per month. 
  
 3.4    Bonus.    The Employee shall participate in any management bonus plan adopted by the Company
on terms comparable to other senior officers of the Company. 
  
 3.5    Equity Compensation.    As of the Effective Date, the Employee shall receive (i) 250,000 options to purchase shares of Company common stock under the Company 1999 Stock Option
Plan, pursuant to the Stock Option Agreement attached hereto as Exhibit A, and (ii) 900,000 warrants to purchase shares of Company common stock, pursuant to the Warrant attached hereto as Exhibit B. 
  
 4.    Proprietary
Information.    The Employee shall as of the Effective Date execute and deliver to the Company the Employee Confidential Information and Inventions Agreement attached as Exhibit C hereto. 
  
 5.    Miscellaneous. 
  
 5.1    Waiver.    The
waiver of the breach of any provision of this Agreement shall not operate or be construed as a waiver of any subsequent breach of the same or other provision hereof. 
  
 5.2    Notices.    All notices and other communications under this
Agreement shall be in writing and shall be given by personal or courier delivery, facsimile or first class mail, certified or registered with return receipt requested, and shall be deemed to have been duly given upon receipt if personally delivered
or delivered by courier, on the date of transmission if transmitted by facsimile, or three days after mailing if mailed, to the addresses of the Company and the Employee contained in the records of the Company at the time of such notice. Any party
may Change such party’s address for notices by notice duly given pursuant to this Section 5.2. 
  

 4 

 5.3    Headings.    The section headings used in
this Agreement are intended for convenience of reference and shall not by themselves determine the construction or interpretation of any provision of this Agreement. 
  
 5.4    Governing Law.    This Agreement shall be governed by and
construed in accordance with the laws of the State of California applicable to contracts entered into and wholly to be performed within the State of California by California residents. 
  
 5.5    Survival of Obligations.    This Agreement shall be binding
upon and inure to the benefit of the executors, administrators, heirs, successors, and assigns of the parties; provided, however, that except as herein expressly provided, this Agreement shall not be assignable either by the Company (except to an
affiliate or successor of the Company) or by the Employee without the prior written consent of the other party. 
  
 5.6    Counterparts.    This Agreement may be executed in one or more counterparts, all of which
taken together shall constitute one and the same Agreement. 
  
 5.7    Withholding.    All sums payable to the Employee hereunder shall be reduced by all federal, state, local, and other withholdings and similar taxes and payments required by
applicable law. 
  
 5.8    Enforcement.    If any portion of this Agreement is determined to be invalid or unenforceable, such portion shall be adjusted, rather than voided, to achieve the intent of the
parties to the extent possible, and the remainder shall be enforced to the maximum extent possible. 
  
 5.9    Entire Agreement; Modifications.    Except as otherwise provided herein or in the exhibits
hereto, this Agreement represents the entire understanding among the parties with respect to the subject matter of this Agreement, and this Agreement supersedes any and all prior and contemporaneous understandings, agreements, plans, and
negotiations, whether written or oral, with respect to the subject matter hereof, including, without limitation, any understandings, agreements, or obligations respecting any past or future compensation, bonuses, reimbursements, or other payments to
the Employee from the Company. All modifications to the Agreement must be in writing and signed by each of the parties hereto. 
  
 5.10    Arbitration.    Any controversy or claim arising out of or relating to this Agreement
(whether in contract or tort, or both) shall be determined by binding arbitration at San Diego, California, in accordance with the commercial arbitration rules of the American Arbitration Association, by a panel of three arbitrators, one chosen by
each of the parties and the third by the two so chosen. If the two arbitrators cannot agree on a third, then the third shall be appointed in accordance with such rules. The prevailing party in any arbitration proceeding shall be awarded reasonable
attorneys fees and costs of the proceedings. The arbitration award shall be final, and may be entered in and enforced by any court having jurisdiction. 
  

 5 

 IN WITNESS WHEREOF, the parties hereto have executed this Employment Agreement as of the date set forth
in the first paragraph. 
  
  

			
	MOLECULAR IMAGING CORPORATION
		
	By:	 	 /s/    Steven J. Davis         

	 Title:
	 	 Vice President of Administration

  
  

	
	EMPLOYEE
	
	 /s/    Kenneth C. Frederick
        

	 Kenneth C. Frederick

  

 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}]]